Chris Hogg

Chris Hogg

Healthcare founder, operator, product and data geek, now building with AI

Founder and operator in digital health and virtual care since 2011. Made chronic disease management data-driven and proactive at Marley Medical. Helped scale Propeller Health as COO, CCO and head of product through its acquisition by ResMed. Founded 100Plus, an early longevity company, in 2011 and sold to PracticeFusion. Now applying AI to unlock health data, accelerate rare disease diagnosis, and reimagine clinical research and patient journeys. Advises growth-stage companies on data strategy, product, and go-to-market. Currently focused on pharma-funded DTP solutions that connect manufacturers and virtual care providers to increase patient access to specialty and subspecialty care.


Partnering with Pharma

Structuring partnerships between life science companies and innovative healthcare startups.

Life Sciences

LillyLilly
EisaiEisai
BiogenBiogen
GSKGSK
NovartisNovartis
AstraZenecaAstraZeneca
Boehringer IngelheimBoehringer Ingelheim

Digital Health & Virtual Care

Propeller HealthPropeller Health
SynapticureSynapticure
Heartbeat HealthHeartbeat Health
AmplifyMDAmplifyMD
LiverRightLiverRight

Data Products (now with AI)

Designing and building data products that turn data into patient insight and proactive care.

Propeller Health patient app — daily asthma forecast and connected inhaler

Propeller Health — Patient App

Physician dashboard — patient vitals, lab results, and treatment management

Marley Medical — Physician Dashboard

Go-to-Market Strategy

Unravelling the complexity of healthcare GTM. Usually the hard part of healthcare innovation is how to get paid.

YourProductPayersHealthSystemsPharmaEmployersDTCGov/CMS

HoggHealth Consulting

Fractional Product & GTM Leader

2025 – Present

Helping growth-stage companies with product, data, and GTM strategies. Currently focused on pharma DTP programs for patients with complex and rare diseases. Recent partnerships between manufacturers (Lilly, Eisai, Biogen, UCB) and virtual care providers (Synapticure, Heartbeat Health, LiverRight, AmplifyMD)

Marley Medical

Sold to Starlight

Co-founder & CEO

2021 – 2024

Virtual care and fee-for-service chronic disease management. Connected health and data-driven. Funded by a16z, CRV, Rock Health

Propeller Health

Acquired by ResMed

COO, CCO & Head of Product

2014 – 2020

Digital therapeutics for asthma and COPD. Scaled product, commercial operations, and pharma partnerships. 7 patents

Practice Fusion

Acquired by Allscripts

Head of Data Science

2013 – 2014

Built data science team and EHR data products for 100K+ physicians. Created the foundation of Practice Fusion's pharma data business, now part of Veradigm

100Plus

Acquired by Practice Fusion

Co-founder & CEO

2011 – 2013

Early longevity company using data and predictive analytics. Funded by Founders Fund, Greylock, Felicis Ventures


Which states have highest diabetes?AI → SQLTXMSWVALAsk in EnglishAI translatesGet insights

Data & Analytics

Feb 2026

Open Health Data Hub

Natural language access to federal health data

Ask questions in plain English about 700M+ records across Medicaid, Medicare, BRFSS, and NHANES. AI translates your questions into SQL queries and delivers interactive tables and charts — no technical expertise required. Over 2,000 queries from 300+ users to date.

Next.jsClaude AIDuckDBRechartsVercel
Visit Project
SymptomsPtosisDiplopiaDysphagiaLimb weaknessFatigueSpecialist AgentsSpecialist 1Specialist 2Specialist 3Diagnoses1.Myasthenia Gravis2.Lambert-Eaton3.Botulism4.Muscular Dystrophy5.Motor Neuron DiseasePhenopacket2Prompt BenchmarkCorrect rare disease diagnosis in top-K resultsSystemNTop-1Top-3Top-5Top-10SecondLook14235.2%51.4%55.6%55.6%Exomiser *5,21335.5%46.3%58.5%o1-preview5,21323.6%31.2%36.8%GPT-4o5,213~20%~27%~31%* Exomiser has access to patient genetic data; SecondLook does not.Source: Phenopacket2Prompt — Zenodo DOI: 10.5281/zenodo.15065293

Clinical Decision Support

Jan 2026

Second Look

AI-powered rare disease differential diagnosis

A multi-agent AI pipeline that helps patients navigate the diagnostic odyssey for rare diseases. Input symptoms through a guided form and receive a prioritized differential grounded in a curated knowledge base of 7,000+ rare and orphan diseases.

Next.jsGPT-4.6ClaudeMDXRadix UI
Visit Project
1DesignProtocol2EnrollParticipants3CollectPRO Data4AnalyzeResultsSTUDY LIFECYCLE

Clinical Research

Jan 2026

N of One

Design and conduct observational clinical studies

AI-powered platform for single-patient observational studies with automated protocol generation. Sponsors create studies, participants join via invitation to complete Patient-Reported Outcome surveys with built-in compliance tracking.

Next.jsSupabaseOpenAIResendPlaywright
Visit Project
PSarah, 34Myasthenia GravisWhat treatments haveyou tried?I started with pyridostigmineand later added azathioprine.IVIG helped during flares.How is your daily life?

Research Tools

Oct 2025

Synthetic Patients for Research

Digital personas of patients with rare disease

Learn from AI-generated patient personas representing rare disease experiences. Ask about their symptoms, treatments, daily challenges, and opinions to inform research, drug development, and clinical trial design.

Next.jsOpenAISupabaseRadix UI
Visit Project
r/migraineMagnesium changed my life...r/migraineTried Aimovig for 6 months...r/ChronicPainBotox injections worked...r/migraineRiboflavin + CoQ10 combo...AIAnalysisTreatment EffectivenessMagnesium78%Aimovig66%Botox56%Riboflavin45%

Real-World Evidence

Sep 2025

RedditRx

Mine Reddit for real-world treatment insights

Analyze Reddit discussions to discover what interventions real patients report working for specific medical problems. Surfaces community-driven treatment experiences and sentiment at scale.

Next.jsAI AnalysisReddit Data
Visit Project
Partnership ScorecardMarket Fit85%Capabilities72%Scale60%Compliance90%OVERALLB+

Business Intelligence

Feb 2025

Will Pharma Like Me?

Assess your pharma partnership potential

Enter your company URL and get an AI-powered assessment of your fit for pharmaceutical partnerships. Analyzes your positioning, offerings, and market alignment against pharma partner selection criteria.

Next.jsAI AnalysisWeb Scraping
Visit Project
Ehlers-Danlos SyndromePrevalence: 1 in 5,000SYMPTOMSJoint hypermobilitySkin hyperextensibilityChronic pain and fatigueTREATMENTPhysical therapy, pain management,genetic counselingGenetic

Health Education

Jan 2025

What is that Disease?

Instant comprehensive disease profiles

Enter any disease name and receive a detailed AI-generated profile covering symptoms, prevalence, treatments, prognosis, and related conditions. A quick-reference tool for patients, caregivers, and researchers.

Next.jsOpenAITailwind CSS
Visit Project